Two Sigma Investments, LP Renalytix PLC Transaction History

Two Sigma Investments, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.33 - $1.61 $2,876 - $14,032	-8,716 Reduced 13.21%	57,258 $22,000
Q3 2023 Nov 14, 2023	BUY	$1.51 - $4.01 $99,620 - $264,555	65,974 New	65,974 $105,000
Q3 2022 Nov 14, 2022	BUY	$1.19 - $2.78 $41,102 - $96,021	34,540 New	34,540 $44,000
Q2 2022 Aug 15, 2022	SELL	$2.45 - $7.81 $132,148 - $421,255	-53,938 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.88 - $15.9 $35,462 - $95,892	6,031 Added 12.59%	53,938 $373,000
Q4 2021 Feb 14, 2022	BUY	$13.43 - $27.4 $643,391 - $1.31 Million	47,907 New	47,907 $762,000

554K

Ticker RNLX
Exchange OTC
Sector Healthcare
Industry Health Information Services
Shares Outstandng 37,445,900
Market Cap $5.62M
Description
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.